Current Position:
Professor of Microbiology and NERC Independent Research Fellow
Institution:
University of Exeter
Discipline:
Ecology & Evolutionary Microbiology
Recognized for: Discovering how environmental factors drive evolution of the bacterial immune system CRISPR in concert with bacteria-infecting viruses, or phages. A greater understanding of the evolution of the CRISPR immune system may aid in tackling the problem of anti-microbial resistance.
Edze Westra
Areas of Research Interest and Expertise: Evolutionary Biology, Gene Editing, Bacterial Immunity, Antimicrobial Resistance, Phage Biology
Previous Positions:
BSc, Wageningen University, Netherlands MSc, Wageningen University, Netherlands PhD, Wageningen University, Netherlands Marie Curie Fellow, University of Exeter, UK
Research Summary:
Prof. Edze Westra’s work seeks to understand how selection pressures drive the evolution of bacterial defense strategies. Bacteria and bacteria-infecting viruses (known as phages) maintain a host-parasite relationship. When unobstructed, viruses infect bacteria and replicate until the bacteria is destroyed. Thus, bacteria have evolved a molecular immune response to fight infection—a mechanism that is key to their survival. Similarly, phages evolve to overcome bacterial immunity, resulting in a co-evolutionary arms race between the bacteria and phage. Using a combination of evolutionary theory, lab experiments, and genetic information, Westra studies the evolution of the adaptive bacterial immune system CRISPR-Cas, a dynamic group of proteins that aid bacteria in fighting off viruses. Westra first pioneered research into the detailed mechanism of CRISPR-Cas by demonstrating that a protein complex containing both CRISPR-associated proteins and virus-targeting genetic material is necessary for immunity function. Such findings were foundational for the field of CRISPR-associated gene-editing research, and he has since provided further studies of CRISPR-Cas regulation, high-resolution visualization of the CRISPR-Cas proteins, and identification of CRISPR-evading mutations within viruses. Further, Westra identified factors that determine whether or not the bacterial CRISPR-Cas system will be engaged in fighting viral infections, which has helped to resolve a long-standing discrepancy between nature- and lab-based studies. Westra’s work on interactions between bacteria and their parasites has provided key insight into methods for successfully predicting and manipulating evolution of CRISPR-Cas antiviral immunity and is indispensable to an understanding of antibiotic resistance, the development of novel antimicrobials, and bacteria-enabled biotechnology.
“Identifying new ways to deal with antimicrobial resistant pathogens is one of the most important challenges of our society. Bacteriophages can help us to treat infections caused by resistant and rapidly evolving bacterial pathogens. I expect this recognition from the Blavatnik Family Foundation for the work from my lab will boost further evolutionary research into bacteria-phage coevolution, and ultimately lead to new treatment strategies.”